TY  - JOUR

T1  - Editorial [ Hot-topic: Molecularly Targeted Therapies in Breast Cancer Bone Metastases (Executive Editor: Philippe Clezardin)]

JO  - Current Pharmaceutical Design

PY  - 2010/01/01

AU  - Clezardin P

ED  - 

DO  - DOI: 10.2174/138161210791033996

PB  - Bentham Science Publishers Ltd.

VL  - 16

IS  - 11

SP  - 1260

EP  - 1261

Y2  - 2025/10/26

ER  -